I5T-MC-AACG - ClinicalTrials.gov - NCT03367403
I5T-MC-AACG - ClinicalTrials.gov - NCT03367403
Key Requirements
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participant must have gradual and progressive change in memory for at least 6 months
Participant must be able to have a positron emission tomography (PET) scan
Participant must be able to have an magnetic resonance imaging (MRI) scan - Participant receiving treatment with one of the symptomatic Alzheimer's drugs must be on a stable dose for at least 2 months
Participant must have a reliable study partner with whom they live or have regular contact (at least 10 hours of communication each week), and who can come to study visits
Participants must NOT
Trial Summary
Conditions the trial is for
Early Symptoms of Alzheimer's Disease
What the trial is testing?
LY3002813, Placebo (IV),
Could I receive a Placebo?
yes
Enrollment Goal
266
Trial Dates
December 2017 - November 2021
Trial Phase
2
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participant must have gradual and progressive change in memory for at least 6 months
Participant must be able to have a positron emission tomography (PET) scan
Participant must be able to have an magnetic resonance imaging (MRI) scan - Participant receiving treatment with one of the symptomatic Alzheimer's drugs must be on a stable dose for at least 2 months
Participant must have a reliable study partner with whom they live or have regular contact (at least 10 hours of communication each week), and who can come to study visits
Participants must NOT
Trial Summary
Conditions the trial is for
Early Symptoms of Alzheimer's Disease
What the trial is testing?
LY3002813, Placebo (IV),
Could I receive a Placebo?
yes
Enrollment Goal
266
Trial Dates
December 2017 - November 2021
Trial Phase
2
Trial Locations
Hide locations not currently recruiting